Intestinal ischemia and the gut-liver axis: An in vitro model

Journal of Surgical Research

Volumn 88, Issue 2, 2000, Pages 160-164

  Towfigh, Shirin ^a,b   Heisler, Tracy ^a,b   Rigberg, David A ^a,b   Hines, O Joe ^a,b   Chu, Jason ^a,b   McFadden, David W ^a,b   Chandler, Charles ^a,b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UCLA MEDICAL CENTER   (United States)

Author keywords

Cytokine; Gut liver axis; Interleukin 6; Ischemia; Kupffer cell; Tumor necrosis factor

Indexed keywords

ARABINOGALACTAN; INTERLEUKIN 6; TRYPAN BLUE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL HYPOXIA; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; IN VITRO STUDY; INTESTINE EPITHELIUM CELL; INTESTINE ISCHEMIA; KUPFFER CELL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; ULTRACENTRIFUGATION;

EID: 0033982697     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1999.5767     Document Type: Article

References (31)

1. Deitch E. A. The role of intestinal barrier failure and bacterial translocation in the development of systemic infection and multiple organ failure. Arch. Surg. 125:1990;403.
2. Boley S. J., Brandt L. J., Sammartano R. J. History of mesenteric ischemia: The evolution of a diagnosis and management. Surg. Clin. North Am. 77:1997;275.
3. Levine J. S., Jacobson E. D. Intestinal ischemic disorders. Dig. Dis. 13:1995;3.
4. Chandler C. F., Lane J. S., Waxman K. S. Seatbelt sign following blunt trauma is associated with increased incidence of abdominal injury. Am. Surg. 63:1997;885.
5. Kafie F., Tominaga G. T., Yoong B., Waxman K. Factors related to outcome in blunt intestinal injuries requiring operation. Am. Surg. 63:1997;889.
6. Cripps N. P., Cooper G. J. Intestinal injury mechanisms after blunt abdominal impact. Ann. R. Coll. Surg. Engl. 79:1997;115.
7. Valentine R. J., Hagino R. T., Jackson M. R., Kakish H. B., Bengtson T. D., Clagett G. P. Gastrointestinal complications after aortic surgery. J. Vasc. Surg. 28:1998;404.
8. Schütz A., Eichinger W., Breuer M., Gansera B., Kemkes B. M. Acute mesenteric ischemia after open heart surgery. Angiology. 49:1998;267.
9. Levison J. A., Halpern V. J., Kline R. G., Faust G. R., Cohen J. R. Perioperative predictors of colonic ischemia after ruptured abdominal aortic aneurysm. J. Vasc. Surg. 29:1999;40.
10. Bryant D. S., Pellicane J. V., Davies R. S. Nonocclusive intestinal ischemia: Improved outcome with early diagnosis and therapy. Am. Surg. 63:1997;334.
11. Ward D., Vernava A. M., Kaminski D. L., Ure T., Peterson G., Garvin P., Arends T. W., Longo W. E. Improved outcome by identification of high-risk nonocclusive mesenteric ischemia, aggressive reexploration, and delayed anastomosis. Am. J. Surg. 170:1995;577.
12. Rixen D., Siegel J. H., Friedman H. P. "Sepsis/SIRS", physiologic classification, severity stratification, relation to cytokine elaboration and outcome prediction in posttrauma critical illness. J. Trauma. 41:1996;581.
13. Baue A. E. MOF/MODS, SIRS: An update. Shock. 6:1996;S1.
14. Baue A. E., Durham R., Faist E. Systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), multiple organ failure (MOF): Are we winning the battle. Shock. 10:1998;79.
15. Tamion F., Richard V., Lyoumi S., Daveau M., Bonmarchand G., Leroy J., Thuillez C., Lebreton J. P. Gut ischemia and mesenteric synthesis of inflammatory cytokines after hemorrhagic or endotoxic shock. Am. J. Physiol. 273:1997;G314.
16. Zhu X. L., Zellweger R., Zhu X. H., Ayala A., Chaudry I. H. Cytokine gene expression in splenic macrophages and Kupffer cells following haemorrhage. Cytokine. 7:1995;8.
17. Ertel W., Morrison M. H., Ayala A., Chaudry I. H. Hypoxemia in the absence of blood loss or significant hypotension causes inflammatory cytokine release. Am. J. Physiol. 269:1995;R160.
18. Scannell G., Waxman K., Kaml G. J., Ioli G., Gatanaga T., Yamamoto R., Granger G. A. Hypoxia induces a human macrophage cell line to release tumor necrosis factor-alpha and its soluble receptors in vitro. J. Surg. Res. 54:1993;281.
19. Abbas A. K., Lichtman A. H., Pober J. S. Cellular and Molecular Immunology. 1991;W.B. Saunders, Philadelphia.
20. Roumen R. M., Hendriks T., van der Ven-Jongekrijg J., Nieuwenhuijzen G. A., Sauerwein R. W., van der Meer J. W., Goris R. J. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock, and severe blunt trauma: Relation with subsequent adult respiratory distress syndrome and multiple organ failure. Ann. Surg. 218:1993;769.
21. van der Poll T., Lowry S. F. Tumor necrosis factor in sepsis: Mediator of multiple organ failure or essential part of host defense. Shock. 3:1995;1.
22. Abraham E., Wunderink R., Silverman H., Perl T. M., Nasraway S., Levy H., Bone R., Wenzel R. P., Balk R., Allred R. Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome: A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. JAMA. 273:1995;934.
23. Beutler B., Milsark I. W., Cerami A. C. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science. 229:1985;869.
24. Horn K. D. Evolving strategies in the treatment of sepsis and systemic inflammatory response syndrome (SIRS). Q. J. Med. 91:1998;265.
25. Youker K., Smith C. W., Anderson D. C., Miller D., Michael L. H., Rossen R. D., Entman M. L. Neutrophil adherence to isolated adult cardiac myocytes: Induction by cardiac lymph collected during ischemia and reperfusion. J. Clin. Invest. 89:1992;602.
26. Ogle C. K., Wu J. Z., Mao X., Szczur K., Alexander J. W., Ogle J. D. Heterogeneity of Kupffer cells and splenic, alveolar, and peritoneal macrophages for the production of TNF, IL-1, and IL-6. Inflammation. 18:1994;511.
27. O'Neill P. J., Ayala A., Wang P., Ba Z. F., Morrison M. H., Schultze A. E., Reich S. S., Chaudry I. H. Role of Kupffer cells in interleukin-6 release following trauma: Hemorrhage and resuscitation. Shock. 1:1994;43.
28. Monden K., Arii S., Itai S., Sasaoki T., Adachi Y., Funaki N., Tobe T. Enhancement of hepatic macrophages in septic rats and their inhibitory effect on hepatocyte function. J. Surg. Res. 50:1991;72.
29. Sasaoki T., Arii S., Monden K., Itai S., Adachi Y., Funaki N., Higashituji H., Tobe T. Enhancement of rat hepatic macrophages by treatment with interleukin-2 and streptococcal preparation OK432, with reference to antitumor activity, soluble factor production and Ia expression. Cancer Immunol. Immunother. 35:1992;75.
30. Rigberg, D. A, Lane, J. S, Todd, K. E, Centeno, J, Gloor, B, McFadden, D. W, and, Chandler, C. Kupffer cell manipulation influences systemic cytokines in intestinal ischemia/reperfusion, Unpublished data, 1999.
31. Kamimura S., Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology. 22:1995;1304.